CX Institutional Takes $180,000 Position in Biogen Inc. (NASDAQ:BIIB)
CX Institutional acquired a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) in the 1st quarter, Holdings Channel reports. The firm acquired 1,315 shares of the biotechnology company’s stock, valued at approximately $180,000. Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Assenagon Asset Management […]
